Zimmer Holdings has reported a slight decrease in net sales, which reached $1.1 billion in the first quarter of 2013, and attributed the loss to having two fewer billing days in key markets, such as the United States, when compared with last year. Zimmer President and CEO David Dvorak said the company achieved financial commitments in the first quarter and was able to leverage earnings per share growth. Zimmer introduced significant new product offerings during the first quarter and Mr. Dvorak said the company is in position to accelerate top-line growth throughout the rest of the year.
First quarter sales were flat in the Americas, and decreased 4 percent in the Asian Pacific. Spine sales dropped 10 percent in the first quarter, contributing significantly to the overall sales decrease. In the Americas, knee and hip sales decreased by 2 and 1 percent respectively, while overall knee and hip sales were down 1 and 4 percent.
More Articles on Orthopedic Devices:
5 Recent Orthopedic Device & Procedure Launches
Invibio Sponsors First International PEEK Meeting in Philadelphia
Dr. Ross Sherban Uses Eminent Spine Device for Percutaneous Pedicle Screw System
First quarter sales were flat in the Americas, and decreased 4 percent in the Asian Pacific. Spine sales dropped 10 percent in the first quarter, contributing significantly to the overall sales decrease. In the Americas, knee and hip sales decreased by 2 and 1 percent respectively, while overall knee and hip sales were down 1 and 4 percent.
More Articles on Orthopedic Devices:
5 Recent Orthopedic Device & Procedure Launches
Invibio Sponsors First International PEEK Meeting in Philadelphia
Dr. Ross Sherban Uses Eminent Spine Device for Percutaneous Pedicle Screw System